Back to Death Clock

Death Clock

Docplanner Group

docplanner.com • Last scanned 2026-03-31

Visit Site
Death Score23Hard To Kill
docplanner.com

Owns Appointments, Not The AI Secret Sauce

Massive scheduling network protects clinics, but vague 'smart tools' and hidden pricing make the AI defensibility and monetization look shakier than the copy.

Trigger

25,000,000 bookings/month

Trigger

300,000 active doctors

Trigger

100,000,000 monthly patient visits

Score Breakdown

+24 Commodity Pressure

Core scheduling and reputation features are inherently commoditizable and the site leans on marketing language that makes automation sound interchangeable.

"integrated end-to-end solution"commodity language: "smart tools", "end-to-end"appointment booking is a discrete, copyable feature set
+12 Model Dependency

No explicit model ownership shown; vague "integrating smart tools" language hints at thin third-party AI or marketing-forward automation.

"integrating smart tools to provide quicker, more precise diagnoses and treatments"no model or ML platform claimsmarketing-forward claims could mask shallow automation
-18 Workflow Ownership

Clearly owns the repeatable clinic workflow (scheduling, practice management, no-show reduction) — core daily operation for doctors and clinics.

"25,000,000 appointments booked last month""Save time managing visits and cut no-shows by half"practice management + appointment booking as primary product
-8 Distribution Embeddedness

Large, multi-country footprint and huge patient/doctor traffic give genuine distribution muscle and marketplace lock-in across regions.

"100,000,000 patients visit our websites each month""300,000 active doctors trust our solutions""Leader in 13 countries"
-4 Integration Depth

Product claims an "integrated end-to-end solution" and offers practice management, but the site lacks technical integration detail or APIs evidence.

"integrated end-to-end solution"practice management features impliedno explicit integration or API markers
-4 Enterprise Trust

Segmented clinic offerings and multinational presence imply commercial maturity, but no compliance or procurement proof is shown on site.

segmented clinic options by size (2–20 specialists; >20 specialists)offices in multiple countries (global/local presence)claims of leadership in multiple countries but no compliance badges
-12 Switching Cost

High transaction volume and patient-doctor network create real data gravity and habit lock-in that raise switching costs.

"25,000,000 appointments booked last month""100,000,000 patients visit our websites each month"network of 300,000 doctors
-3 Monetization Maturity

Large user and transaction metrics imply revenue channels, but hidden pricing and lack of explicit monetization detail lowers clarity on maturity.

customer proof markers (doctors, bookings, visits)pricing_visibility: hiddensegmented product tiers for clinics
+4 Category Baseline

Vertical workflow products start safer than generic assistants.

vertical workflow
-3 Relative Placement

Slightly safer — large network effects, high transaction volume, and clear workflow ownership justify a small downward adjustment vs. the current score.

Very large network and transaction scale (25M appointments/month; 100M monthly patient visits; 300k doctors) → real data gravity and switching costs.Owns core clinic workflow (scheduling, practice management, no-show & retention features) — daily operational lock‑in for buyers.Geographic leadership (leader in 13 countries) and segmented clinic tiers imply commercial maturity and distribution embeddedness.

Top Risks

  • Commoditizable scheduling features
  • Vague AI claims = wrapper risk
  • Hidden pricing undermines monetization proof
  • Dependence on network effects without clear tech moat

Top Defenses

  • Massive doctor and patient network
  • 25M bookings per month (data gravity)
  • Localized leadership across 13 countries
  • Embedded daily scheduling workflow

Why We Said This

The site presents a classic vertical workflow play: deep ownership of appointment booking and practice management with impressive scale (300k doctors, 25M bookings/month, 100M visits/month). That network produces real switching costs and distribution strength. However, technical slides are thin: AI is glossed as "smart tools" with no models, APIs, or integration proof, and pricing is hidden. That combination makes core automation and ML value appear copyable, even as the marketplace footprint remains a strong defensive asset.

Evidence

"integrating smart tools to provide quicker, more precise diagnoses and treatments"

Evidence

"integrated end-to-end solution"

Evidence

"25,000,000 appointments booked last month"

Evidence

"100,000,000 patients visit our websites each month"

Evidence

"300,000 active doctors trust our solutions"

Evidence

"Save time managing visits and cut no-shows by half"

Evidence

"Leader in 13 countries"

Signal Surface

uses vague phrase "integrating smart tools" without technical detailmarketing-forward claims ("end-to-end", "smart tools") that could mask shallow automationnetwork scale: large user base of patients and doctors (100M monthly patient visits; 300k doctors)geographic leadership in multiple countries (leader in 13 countries)high transaction volume (tens of millions of bookings monthly) that supports network effects
segmented clinic options by size (2 to 20 specialists; more than 20 specialists)offices in multiple countries (global/local presence)

Product type: Healthcare marketplace + practice/clinic management platform (appointment booking and patient-doctor ecosystem) • Buyer: Doctors and clinics (practice owners / clinic administrators) • Pricing: hidden • Archetype: vertical workflow • Score model: site-scan-score-v4

Pages Analyzed